Archive for Type I Gaucher Disease

VPRIV

VPRIV (velaglucerase alfa) is a medication used for long-term enzyme replacement therapy in patients 4 years of age and older with type 1 Gaucher disease.

Cerezyme

Cerezyme is a hydrolytic lysosomal glucocerebrosidase-specific enzyme indicated for treatment
of adults and pediatric patients 2 years of age and older with Type 1 Gaucher disease.